Xiejia Jiao

Mr. Xiejia Jiao


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2023 in Translational Oncology
Verified
Journal Article
Open access
QLQingbo Li
Qingbo Li
XXXiao Xu
Xiao Xu
XJXiejia Jiao
Xiejia Jiao
Growing evidence demonstrated that cuproptosis play critical roles in human cancers. We aimed to identify the roles of cuproptosis related genes (CRGs) in prognosis and immunity of Ewing's sarcoma. The data of GSE17674 and GSE63156 were obtained from GEO. The expression of 17 CRGs and immune cells were explored, then correlation was analyzed. Based on CRGs, two molecular clusters were identified by consensus clustering algorithm. KM survival and IME features including immune cells, immune response, checkpoint genes between clusters were evaluated. NFE2L2, LIAS, and CDKN2A were screened out as prognostic signatures by univariate, LASSO and step regression. A risk model was established, and validated by KM method with p = 0.0026, and perfect AUC values. The accuracy of risk model was also well validated in external dataset. A nomogram was constructed and evaluated by calibration curves and DCA. Low level of immune cells, immune response, and enriched checkpoint genes were found in high-risk group. GSEA of signatures and GSVA of ES-related pathways revealed the potential molecular mechanism involved in ES progression. Several drugs showed sensitivity to ES samples. DEGs between risk groups were screened out, and function enrichment was conducted. Finally, scRNA analysis of GSE146221 was done. NFE2L2, and LIAS played crucial role in the evolution of ES by pesudotime and trajectory methods. Our study provided new aspects for further research in ES.

14 April 2026 in Genes
Verified
Journal Article
Open access
PDF file
ZWZhenyang Wang
Zhenyang Wang
YCYongqin Chen
Yongqin Chen
YYYuxuan Yang
Yuxuan Yang
BXBiteng Xu
Biteng Xu
XJXiejia Jiao
Xiejia Jiao
LQLei Qi
Lei Qi
Background: This study investigates the role of N6-methyladenosine (m6A) regulators in osteoporosis (OP) and their interplay with the immune microenvironment, aiming to identify potential m6A-related biomarkers for OP risk assessment and treatment. Methods: Transcriptomic data from GEO datasets were analyzed for differential expression of 22 m6A regulators and immune infiltration patterns. Consensus clustering and m6Ascore grouping defined molecular subtypes, while machine learning algorithms identified potential biomarkers, leading to the construction and validation of a nomogram. Experimental validation involved peripheral blood monocytes (PBMCs) transcriptome sequencing and Western blot of bone tissue. Results: FTO, HNRNPC, and METTL4 were upregulated, while CBLL1 and YTHDF2 were downregulated in OP, with two distinct m6A modification patterns and immune phenotypes identified. METTL4, HIRA, MATN4, and YTHDF2 were selected as potential biomarkers, and the nomogram demonstrated favorable predictive performance in training and external datasets. Single-cell RNA sequencing confirmed the cellular distribution of these biomarkers. HIRA heterogeneity in Marrow Mesenchymal Stem Cells (BMSCs) was associated with distinct cell–cell communication patterns. Transcriptome sequencing confirmed HIRA RNA downregulation in OP PBMCs, and Western blot verified decreased HIRA protein in OP bone tissue. Conclusions: This study establishes a potential m6A-related biomarker signature for OP and provides multi-level experimental evidence that HIRA is a consistently downregulated biomarker, linking epigenetic modification to immune dysregulation in osteoporosis.

10 October 2026 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
ZWZhenyang Wang
Zhenyang Wang
XLXiangyu Li
Xiangyu Li
XJXiejia Jiao
Xiejia Jiao
Zero-profile anterior cervical discectomy and fusion (ACDF) constructs vary in screw number and trajectory, but their effects on immediate stability and lo

9 July 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YCYongqin Chen
Yongqin Chen
WZWencan Zhang
Wencan Zhang
XXXiao Xu
Xiao Xu
BXBiteng Xu
Biteng Xu
YYYuxuan Yang
Yuxuan Yang
XJXiejia Jiao
Xiejia Jiao
Background: Cuproptosis is copper-induced cell death. Copper metabolism related genes (CMRGs) were demonstrated that used to assess the prognosis out of tumors. In the study, CMRGs were tested for their effect on TME cell infiltration in Ewing’s sarcoma (ES).Methods: The GEO and ICGC databases provided the mRNA expression profiles and clinical features for downloading. In the GSE17674 dataset, 22prognostic-related copper metabolism related genes (PR-CMRGs) was identified by using univariate regression analysis. Subsequently, in order to compare the survival rates of groups with high and low expression of these PR-CMRGs,Kaplan-Meier analysis was implemented. Additionally, correlations among them were examined. The study employed functional enrichment analysis to investigate probable underlying pathways, while GSVA was applied to evaluate enriched pathways in the ES (Expression Set). Through an unsupervised clustering algorithm, samples were classified into two clusters, revealing significant differences in survival rates and levels of immune infiltration.Results: Using Lasso and step regression methods, five genes (TFRC, SORD, SLC11A2, FKBP4, and AANAT) were selected as risk signatures. According to the Kaplan-Meier survival analysis, the high-risk group had considerably lower survival rates than the low-risk group(p=6.013e-09). The area under the curve (AUC) values for the receiver operating characteristic (ROC) curve were 0.876, 0.883, and 0.979 for 1, 3, and 5 years, respectively. The risk model was further validated in additional datasets, namely GSE63155, GSE63156, and the ICGC datasets. To aid in outcome prediction, a nomogram was developed that incorporated risk levels and clinical features. This nomogram’s performance was effectively validated through calibration curves.Additionally, the study evaluated the variations in immune infiltration across different risk groups, as well as high-expression and low-expression groups. Importantly, several drugs were identified that displayed sensitivity, offering potential therapeutic options for ES.Conclusion: The findings above strongly indicate that CMRGs play crucial roles in predicting prognosis and immune status in ES.

19 May 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
YCYongqin Chen
Yongqin Chen
XJXiejia Jiao
Xiejia Jiao
BXBiteng Xu
Biteng Xu
YYYuxuan Yang
Yuxuan Yang
XXXiao Xu
Xiao Xu
LQLei Qi
Lei Qi

15 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ZWZhenyang Wang
Zhenyang Wang
YCYongqin Chen
Yongqin Chen
YYYuxuan Yang
Yuxuan Yang
LQLei Qi
Lei Qi
BXBiteng Xu
Biteng Xu
XJXiejia Jiao
Xiejia Jiao
Background: Ewing’s sarcoma (ES) is a malignant osseous neoplasm characterized by a dismal prognosis, particularly in its metastatic variant. The significance of disulfidptosis—a newly identified cell death mechanism induced by cystine metabolic imbalance and mitochondrial dysfunction—has yet to be investigated in ES. Thus, the aim of this study was to assess the prognostic significance of disulfidptosis-related genes (DRGs) in this disease. Methods: We analyzed four GEO datasets to examine nine DRGs through differential expression, co-expression networks, and functional enrichment analyses. A predictive risk signature was developed using unsupervised clustering, Cox regression, and LASSO. Drug sensitivity was predicted using the GDSC database, and immune infiltration was quantified by ssGSEA. Single-cell RNA sequencing data was analyzed to explore DRGs distribution and functional heterogeneity. Molecular docking simulations were performed to evaluate interactions between DRGs and chemotherapeutic agents. Experimental validation of key DRGs was conducted in RD-ES cells using PCR and Western blotting, followed by functional studies of NDUFA11 via siRNA knockdown, assessing proliferation, migration, and invasion. Results: Eight of nine DRGs were dysregulated in ES tissues. A five-gene risk model ( NDUFS1 , LRPPRC , NDUFA11 , OXSM , NUBPL ) stratified patients into high- and low-risk groups with significantly different survival outcomes. The risk score was an independent prognostic indicator. Drug sensitivity analysis revealed enhanced response to microtubule inhibitors in the low-risk group. Single-cell analysis demonstrated predominant enrichment of these five DRGs in malignant ES cells. NDUFA11 -high malignant cells exhibited distinct metabolic and signaling pathway enrichment and stronger intercellular communication with the tumor microenvironment. Molecular docking confirmed stable binding between DRGs proteins and chemotherapeutic compounds. Experimental validation confirmed dysregulation of all five DRGs at both RNA and protein levels in RD-ES cells. Functional studies revealed that NDUFA11 knockdown significantly suppressed ES cell proliferation, migration, and invasion. Conclusion: This study provides the first prognostic signature connected to disulfidptosis for ES. Functional validation of NDUFA11 highlights its oncogenic role and potential as a therapeutic target. Single-cell analysis further elucidates the metabolic heterogeneity and microenvironmental interactions underlying ES progression.